Molecular View Of Key Epigenetic Regulator Revealed By Kobor Laboratory
Main Category: Lymphoma / Leukemia / MyelomaAlso Included In: Genetics; Biology / Biochemistry
Article Date: 11 Dec 2009 - 1:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
In a paper published this week in the journal Proceedings of the National Academy of Sciences, Dr. Michael Kobor's laboratory reported the structure and function of a key player in regulating chromatin in yeast and humans. Chromatin, a dynamic DNA-protein complex, is involved in numerous cellular processes and has profound effects on human health and disease. This study is a major advancement in elucidating the role and structure of an epigenetic regulator commonly involved in human leukemia and other human diseases.
Chromatin biology is central to epigenetics, which is a framework for environmental regulation of genome function. The chromatin regulator Yaf9 contains a module called the YEATS domain, which is found in many other proteins implicated in chromatin regulation and cancer. The molecular structure and function of YEATS domain proteins has been an unresolved mystery in the field of epigenetics. Using advanced X-ray crystallography, the team gained the first detailed picture at atomic resolution of the YEATS domain. Furthermore, the authors showed that its function is conserved from yeast to human, and revealed a requirement of the YEATS domain for two different mechanisms by which chromatin can be modified.
Alice Wang and Julia Schulze, two PhD candidates in Dr. Kobor's laboratory, performed this work in collaboration with researchers at the University of California, Berkeley.
Source: Nicki Kahnamoui
University of British Columbia
Visit our lymphoma / leukemia / myeloma section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/173634.php>
APA
http://www.medicalnewstoday.com/releases/173634.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



